Thermo Fisher Scientific (TMO) Misses Q2 EPS by 28c; lowers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Thermo Fisher Scientific (NYSE: TMO) | Delayed: 705.15 +6.81 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $698.34 | 52 Week High | $160.68 | |||
| Open | $708.00 | 52 Week Low | $119.75 | |||
| Day High | $712.17 | P/E | 201.47 | |||
| Day Low | $691.96 | EPS | $3.50 | |||
| Volume | 1,731,568 | |||||
